Lee F. Peng

3.4k citations
30 papers · 2.3k indexed · h-index 22
Topics
Hepatitis C virus research (20 papers)Liver Disease Diagnosis and Treatment (9 papers)Hepatitis B Virus Studies (7 papers)
Partner nations
United StatesChinaJapan

In The Last Decade

Lee F. Peng

30 papers receiving 2.3k citations

Peers

Lee F. Peng
Comparison fields: 5 of 100
  • Molecular Biology 1.1k
  • Hepatology 834
  • Epidemiology 708
  • Immunology 335
  • Surgery 333
Replace Hidekazu Nakabayashi with:
Hidekazu Nakabayashi Japan
Keng‐Hsin Lan Taiwan
Shilpa Chokshi United Kingdom
Marie Annick Buendia France
Laura Runkel United States
Seng‐Lai Tan United States
Pamela A. Norton United States
Keiko Miyano Japan
Joachim Lupberger France
Gessica Filocamo Italy
Lee F. Peng relative to Hidekazu Nakabayashi Japan Hidekazu Nakabayashi's profile →
Citations per field
00.5×3.4×
Hidekazu Nakabayashi · 1×
Citations per year

Countries citing papers authored by Lee F. Peng

Since Specialization
Citations

This map shows the geographic impact of Lee F. Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lee F. Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lee F. Peng more than expected).

Fields of papers citing papers by Lee F. Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lee F. Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lee F. Peng. The network helps show where Lee F. Peng may publish in the future.

Co-authorship network of co-authors of Lee F. Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Lee F. Peng. A scholar is included among the top collaborators of Lee F. Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lee F. Peng. Lee F. Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 13
2 1
3 58
4 5
5 21
6 3
7 89
8 30
9 20
10 68
11 11
12 50
13 44
14 112
15 164
16 367
17 57
18 340
19 116
20 70

About Lee F. Peng

Lee F. Peng is a scholar working on Hepatology, Epidemiology and Immunology, having authored 30 papers that have together received 2.3k indexed citations. Recurring topics across this work include Hepatitis C virus research (20 papers), Liver Disease Diagnosis and Treatment (9 papers) and Hepatitis B Virus Studies (7 papers). The work is most often cited by research in Hepatology (834 citations), Virology (132 citations) and Epidemiology (708 citations). Lee F. Peng has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Benjamin Z. Stanton, Raymond T. Chung, Wenyu Lin, Stuart L. Schreiber, Andrew W. Tai, Naoya Sakamoto, Leiliang Zhang, Raymond T. Chung, Ramnik J. Xavier and Yair Benita. Their work appears in journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026